ReviewEndocrinology and metabolism clinics of North America2016
Regarding Obesity as a Disease: Evolving Policies and Their Implications.
Review in Endocrinology and metabolism clinics of North America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 138 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
138 citing papers in PubMed, 6 syntheses or guidelines pooled it.
- Efficacy and mechanisms ofFrontiers in pharmacology · 2026Pooled it
- Structural weight stigma in healthcare toward preconception, pregnant, and postpartum women: A systematic review.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025Pooled it
- Obesity in Refugees post-resettlement in a high-income country: a meta-analysis.Journal of racial and ethnic health disparities · 2024Pooled it
- Leveraging deep phenotyping from health check-up cohort with 10,000 Korean individuals for phenome-wide association study of 136 traits.Scientific reports · 2022Pooled it
- Technology-supported Acceptance and Commitment Therapy for chronic health conditions: A systematic review and meta-analysis.Behaviour research and therapy · 2022Pooled it
- Obesity in Adults: A 2022 Adapted Clinical Practice Guideline for Ireland.Obesity facts · 2022Guideline
- Coated glucose microbeads stimulate enteric hormone release and improve glucose tolerance in Phase 1 and 2 clinical trials.Diabetes, obesity & metabolism · 2025Trial
- Effects of the MyBFF@school program on anthropometry and body composition among overweight and obese adolescent schoolchildren.BMC public health · 2025Trial
- Effects of meal type on the bioavailability of vutiglabridin, a novel anti-obesity agent, in healthy subjects.Clinical and translational science · 2024Trial
- The Effect of an Education Module to Reduce Weight Bias among Medical Centers Employees: A Randomized Controlled Trial.Obesity facts · 2022Trial
- Outcomes with Intra-gastric Balloon Therapy in BMI < 35 Non-morbid Obesity: 10-Year Follow-Up Study of an RCT.Obesity surgery · 2021Trial
- Once-Weekly Subcutaneous Semaglutide 2.4 mg Injection is Cost-Effective for Weight Management in Spain.Advances in therapy · 2026Article
- Trends in Use of Obesity Medications and Metabolic and Bariatric Surgery Among All of Us Participants From 2003 to 2023.Obesity (Silver Spring, Md.) · 2026Article
- The important role of comorbidities in the management of obesity.Journal of the Endocrine Society · 2026Review
- Understanding the Impact of Weight on Quality of Life and Willingness to Pay for Obesity Management in the APAC Region.Clinical obesity · 2026Article
- Escherichia coli Nissle 1917 Modulates the RNF150/ELAVL1 Ubiquitination Pathway to Ameliorate Obesity-driven Insulin Resistance in High-fat Diet-fed Mice.Cellular and molecular gastroenterology and hepatology · 2026Article
- Beyond Leptin and Adiponectin: The Diverse Roles of Adipokines in the Myocardial Hypertrophic Process and Heart Failure and Their Potential Contribution in Obesity.International journal of molecular sciences · 2025Review
- Optimizing Biomedical Health Efficiency: Unlocking the Full Potential of Life Science Innovation Through System Design.Therapeutic innovation & regulatory science · 2025Article
- Obesity as a Chronic Disease: A Narrative Review of Evolving Definitions, Management Strategies, and Cardiometabolic Prioritization.Advances in therapy · 2025Review
- Beyond GLP-1 Agonists: An Adaptive Ketogenic-Mediterranean Protocol to Counter Metabolic Adaptation in Obesity Management.Nutrients · 2025Review
78 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
In 2013, the American Medical Association recognized obesity as a complex, chronic disease requiring medical attention. Defining obesity as a disease is a very public process, largely driven by expectation of costs and benefits. Although the public has been slow to embrace this definition, evidence is emerging for broader awareness of influencing factors beyond personal choice. This decision seems to be working with other factors to bring more access to care, less blame for people with the condition, and more favorable conditions for research to identify effective strategies for prevention and clinical care to reduce the impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.